ByteDance finalized a $290 million funding round for its independent AI drug discovery subsidiary, Anew Labs, valuing the entity at…
Read More »Primavera Venture Partners
Entity category: ORGANIZATION
Entity category: ORGANIZATION
ByteDance finalized a $290 million funding round for its independent AI drug discovery subsidiary, Anew Labs, valuing the entity at…
Read More »